| Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors DA Wainwright, AL Chang, M Dey, IV Balyasnikova, CK Kim, A Tobias, ... Clinical cancer research 20 (20), 5290-5301, 2014 | 650 | 2014 |
| Sui generis: gene therapy and delivery systems for the treatment of glioblastoma JR Kane, J Miska, JS Young, D Kanojia, JW Kim, MS Lesniak Neuro-oncology 17 (suppl_2), ii24-ii36, 2015 | 82 | 2015 |
| βIII-tubulin regulates breast cancer metastases to the brain D Kanojia, RA Morshed, L Zhang, JM Miska, J Qiao, JW Kim, P Pytel, ... Molecular cancer therapeutics 14 (5), 1152-1161, 2015 | 67 | 2015 |
| Neural stem cells secreting anti-HER2 antibody improve survival in a preclinical model of HER2 overexpressing breast cancer brain metastases D Kanojia, IV Balyasnikova, RA Morshed, RT Frank, D Yu, L Zhang, ... Stem Cells 33 (10), 2985-2994, 2015 | 54 | 2015 |
| GCN2 is essential for CD8+ T cell survival and function in murine models of malignant glioma A Rashidi, J Miska, C Lee-Chang, D Kanojia, WK Panek, A Lopez-Rosas, ... Cancer Immunology, Immunotherapy 69, 81-94, 2020 | 44 | 2020 |
| Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy JS Young, RA Morshed, JW Kim, IV Balyasnikova, AU Ahmed, ... Expert Opinion on Drug Delivery 11 (11), 1733-1746, 2014 | 33 | 2014 |
| An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transfer JW Kim, JN Glasgow, M Nakayama, F Ak, H Ugai, DT Curiel PloS one 8 (2), e55533, 2013 | 32 | 2013 |
| Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma WK Panek, JR Kane, JS Young, A Rashidi, JW Kim, D Kanojia, ... Oncotarget 8 (51), 89391, 2017 | 31 | 2017 |
| Intratumoral oncolytic adenoviral treatment modulates the glioma microenvironment and facilitates systemic tumor-antigen-specific T cell therapy J Qiao, M Dey, AL Chang, JW Kim, J Miska, A Ling, D M Nettlebeck, ... Oncoimmunology 4 (8), e1022302, 2015 | 31 | 2015 |
| Local application of autologous platelet-rich fibrin patch (PRF-P) suppresses regulatory T cell recruitment in a murine glioma model WK Panek, KC Pituch, J Miska, JW Kim, A Rashidi, D Kanojia, ... Molecular neurobiology 56, 5032-5040, 2019 | 27 | 2019 |
| A dendritic cell-targeted adenoviral vector facilitates adaptive immune response against human glioma antigen (CMV-IE) and prolongs survival in a human glioma tumor model JW Kim, JR Kane, WK Panek, JS Young, A Rashidi, D Yu, D Kanojia, ... Neurotherapeutics 15 (4), 1127-1138, 2018 | 26 | 2018 |
| Therapeutic cell carriers: a potential road to cure glioma JS Young, JW Kim, AU Ahmed, MS Lesniak Expert review of neurotherapeutics 14 (6), 651-660, 2014 | 25 | 2014 |
| A novel single-chain antibody redirects adenovirus to IL13Rα2-expressing brain tumors JW Kim, JS Young, E Solomaha, D Kanojia, MS Lesniak, IV Balyasnikova Scientific reports 5 (1), 18133, 2015 | 23 | 2015 |
| Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters JW Kim, B Auffinger, DA Spencer, J Miska, AL Chang, JR Kane, JS Young, ... Journal of Translational Medicine 14, 1-14, 2016 | 19 | 2016 |
| On the other side: manipulating the immune checkpoint landscape of dendritic cells to enhance cancer immunotherapy BY Kong, H Bolton, JW Kim, PA Silveira, PD Fromm, GJ Clark Frontiers in oncology 9, 50, 2019 | 18 | 2019 |
| A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model MSL Julius W. Kim, Jason Miska, Jacob S. Young, Aida Rashidi, J. Robert Kane ... Mol Ther Oncolytics, 2017 | 18 | 2017 |
| A genetically modified adenoviral vector with a phage display-derived peptide incorporated into fiber fibritin chimera prolongs survival in experimental glioma JW Kim, JR Kane, JS Young, AL Chang, D Kanojia, RA Morshed, J Miska, ... Human gene therapy 26 (9), 635-646, 2015 | 16 | 2015 |
| Gene therapy and virotherapy of gliomas JW Kim, AL Chang, JR Kane, JS Young, J Qiao, MS Lesniak Prog Neurol Surg 32, 112-123, 2018 | 13 | 2018 |
| Unlocking the promise of oncolytic virotherapy in glioma: combination with chemotherapy to enhance efficacy DA Spencer, JS Young, D Kanojia, JW Kim, SP Polster, JP Murphy, ... Therapeutic delivery 6 (4), 453-468, 2015 | 10 | 2015 |
| Neural stem cell‐mediated delivery of oncolytic adenovirus JW Kim, JR Kane, JS Young, AL Chang, D Kanojia, S Qian, DA Spencer, ... Current protocols in human genetics 85 (1), 13.11. 1-13.11. 9, 2015 | 10 | 2015 |
